Key result
Lower TTV DNA load is linked to ~7-fold higher acute rejection odds but poorly predicts infection.
Why the study?
The diagnostic accuracy of torque teno virus viral DNA load for acute rejection and infection after kidney transplantation has not been evaluated.
Does Torque teno virus (TTV) viral DNA load accurately predict acute rejection and infection in kidney transplant recipients?
Meta-Analysis
Does Torque teno virus (TTV) viral DNA load accurately predict acute rejection and infection in kidney transplant recipients?
Answers are grounded in this paper and cite their sources.
TTV viral DNA load may serve as a modest indicator for risk stratification of acute rejection after kidney transplantation, but has poor accuracy for discriminating posttransplant infection.
Torque teno virus (TTV) is a promising novel marker for quantifying the immune function in solid organ recipients, whose diagnostic accuracy of acute rejection (AR) and infection after kidney transplantation (KT) has not been evaluated. We performed a systematic review and meta‐analysis to evaluate the diagnostic accuracy of TTV for discriminating AR and infection after KT. Eleven studies were included in the meta‐analysis. Seven studies focused on the diagnostic accuracy of TTV for AR, and the pooled analysis indicated patients who developed AR had a significant lower TTV viral DNA load (log10 copies/mL, MD: −0.74, p < 0.01). The pooled sensitivity, specificity, and area under the receiver operating characteristics curve for TTV in AR differentiation were 0.61 (0.36−0.82), 0.81 (0.64−0.91), and 0.79 (0.75−0.82), respectively. The overall diagnostic odds ratio (DOR) was 6.74 (2.60−17.50), positive likelihood ratio (PLR) was 3.22 (1.75−5.95), and negative likelihood ratio (NLR) was 0.48 (0.27−0.84), respectively. Similarly, seven studies investigated the infection discrimination and found that patients who subsequently developed posttransplant infection had higher plasma TTV DNA loads (log10 copies/mL, MD: 0.65; p < 0.01) than those remaiing infection‐free. Pooled sensitivity, specificity, and area under the receiver operating characteristics curve for TTV in infection differentiation were 0.72 (0.39−0.91), 0.57 (0.30−0.80), and 0.68 (0.64−0.72), respectively. The overall DOR was 3.28 (95% confidence interval [CI]: 2.08−5.17), the pooled PLR and NLR were 1.65 (95% CI: 1.25−2.18) and 0.50 (95% CI: 0.29−0.86), respectively. TTV might be a modest indicator for risk stratification of AR after KT, but it is a poor to discriminate posttransplant infection.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2023) conducted a meta-analysis in Kidney transplantation. Torque teno virus (TTV) DNA load vs. Patients without acute rejection or infection was evaluated on TTV viral DNA load difference in acute rejection (MD -0.74, p=<0.01). Lower Torque teno virus DNA load was associated with acute rejection with a diagnostic.74, but showed poor accuracy for discriminating posttransplant infection.
Synapse has enriched 10 related papers. Consider them for comparative context: